Congratulations to GemPharmatech and BanJim Enterprise! On November 27th, GemPharmatech announced signing an agreement with Ban Jim Enterprise Co., Ltd. The agreement aims to provide more efficient and accurate biotechnology solutions for researchers and pharmaceutical companies in Taiwan.
 
As Mr. Yih-Sheng, Sid, Kuo, the Market Director of GemPharmatech, stated: "Through close collaboration with local partners, we will jointly provide more efficient and professional biomedical research and development, as well as new drug development solutions for Taiwan's industrial and academic sectors."
 
Read more from Globalbio.
​​​​​​


Left to Right: Peter Chen, CEO of Ban Jim, Sid Kuo, Market Director of GemPharmatech, and Dr. Rick Wong, Chairman of Taiwan College of Laboratory Animal Medicine. (Photo Credit: GemPharmatech)